YB Urban Renewal Residential Development Ltd, formerly known as Cannassure Therapeutics Ltd, is an Israel-based urban renewal company. The Company is engaged mainly in urban renewal projects. In the urban renewal projects sector, the Company partakes in activities that aim to clear out areas of inner cities deemed to be neglected, unused and loosely maintained, in favor of new multifamily housing, business areas, as well as other developments improving the city landscape. The Firm aims to achieve economic, cultural and environmental renewal of the neglected inner city areas. The Company cooperates with a range of specialists in the field of urban renewal with knowledge and experience in urban planning and construction work.

Employees

Sector

Real Estate Development & Operations

More about the company

Quotes

Date	Price	Change	Volume
26-07-20	ILA 615.60	-0.29%	162

Delayed Quote TEL AVIV STOCK EXCHANGE

More quotes

Income Statement and Estimates

More financial data

Market Closed - TEL AVIV STOCK EXCHANGE Other stock markets 06:44:24 2026-07-24 EDT			5-day change	1st Jan Change
615.60 ^ILa	0.00%		0.00%	-15.50%

05-03	Y.B Urban Renewal - Residential Development Ltd Reports Earnings Results for the Full Year Ended December 31, 2025	CI
05-02	Y.B Urban Renewal - Residential Development Ltd Auditor Raises 'Going Concern' Doubt	CI

Market Cap	29.29M 2.93B 9.61M 8.45M 7.86M 7.19M 13.51M 928M 13.77M 93.29M 36.57M 455M 36.06M 35.29M 1.57B	P/E 2024	-4.93x	P/E 2025	-9.22x
Enterprise Value	29.41M 2.94B 9.64M 8.49M 7.89M 7.22M 13.57M 931M 13.82M 93.66M 36.71M 456M 36.2M 35.42M 1.58B	EV / Sales 2024	376x	EV / Sales 2025	-
Free-Float	54.18%	Yield 2024 *	-	Yield 2025	-

05-03	Y.B Urban Renewal - Residential Development Ltd Reports Earnings Results for the Full Year Ended December 31, 2025	CI
05-02	Y.B Urban Renewal - Residential Development Ltd Auditor Raises 'Going Concern' Doubt	CI
11-12	Y.B Urban Renewal - Residential Development Ltd announced that it expects to receive ILS 0.53001 million in funding	CI
25-09-10	Y.B Urban Renewal - Residential Development Ltd Reports Earnings Results for the Half Year Ended June 30, 2025	CI
24-09-01	Y.B Urban Renewal - Residential Development Ltd Reports Earnings Results for the Half Year Ended June 30, 2024	CI
24-07-11	Cannassure Therapeutics Ltd will Change its Name to Y.B URBAN RENEWAL - RESIDENTIAL DEVELOPMENT LTD	CI
24-03-27	Y.B Urban Renewal - Residential Development Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	CI
24-03-26	Y.B Urban Renewal - Residential Development Ltd Auditor Raises 'Going Concern' Doubt	CI
23-08-31	Cannassure Therapeutics Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	CI
23-03-26	Cannassure Therapeutics Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	CI
21-08-09	Cannassure Was Granted A Patent for an Oral Delivery Method of Cannabis and Cannabinoids Compositions by the Israel Patents Authority	CI

21-02-26	DanCann Pharma A/S : publishes Year-end report for 2020	AQ
21-01-18	Cannassure Therapeutics : DanCann Pharma's strategic partner, Cannassure Therapeutics Ltd., enter exclusive licensing agreement regarding topical medical cannabis products based on Lipidor's AKVANO® technology	AQ
21-01-18	Lipidor : and Cannassure enter exclusive licensing agreement regarding topical medical cannabis products based on Lipidor's AKVANO technology	AQ
20-12-15	DanCann Pharma A/S : enter exclusive agreement with Cannassure Therapeutics to be multinational distributor for Scandinavia (Denmark, Norway, Sweden, and Finland)	AQ
20-11-19	Lipidor : publishes interim report for Q3 2020	AQ

Y.B Urban Renewal - Residential Development Ltd Stock

Stocks

YBRD

IL0001110134

Real Estate Development & Operations

Valuation: Y.B Urban Renewal - Residential Development Ltd

Chart: Y.B Urban Renewal - Residential Development Ltd

Latest news : Y.B Urban Renewal - Residential Development Ltd

Press Releases: Y.B Urban Renewal - Residential Development Ltd

Quotes and Performance

Course Extremes

Managers and Directors: Y.B Urban Renewal - Residential Development Ltd

Other Real Estate Development & Operations

Financials

Company Profile

Quotes

Income Statement and Estimates

Current month	-1.97%
1 month	-7.25%
3 months	-17.10%
6 months	-18.27%
Current year	-15.50%

1 week	613.9	615.6
1 month	590	686
Current year	590	799
1 year	590	899
3 years	291	2,075
5 years	291	7,270
10 years	291	34,500

Manager	Title	Age	Since
Ada Bar Kama CEO	Chief Executive Officer	56	2022-03-30
Oren Attiya DFI	Director of Finance/CFO	44	-
Daniel Spira AUD	Comptroller/Controller/Auditor	72	2019-06-25

Director	Title	Age	Since
Shimon Bar-Kama BRD	Director/Board Member	74	2018-12-03
Nir Peles CHM	Chairman	53	2021-12-08
Varda Kalal BRD	Director/Board Member	58	2022-02-13

	2024	2025
Net sales	76K 7.6M 24.92K 21.93K 20.38K 18.67K 35.06K 2.41M 35.71K 242K 94.87K 1.18M 93.56K 91.54K 4.08M	-
Net income	-3.68M -368M -1.21M -1.06M -985K -903K -1.7M -116M -1.73M -11.7M -4.59M -57.04M -4.52M -4.43M -197M	-3M -300M -983K -865K -803K -736K -1.38M -94.86M -1.41M -9.54M -3.74M -46.5M -3.69M -3.61M -161M
Net Debt	980K 98M 321K 283K 263K 241K 452K 31.03M 461K 3.12M 1.22M 15.21M 1.21M 1.18M 52.64M	115K 11.5M 37.71K 33.18K 30.84K 28.24K 53.05K 3.64M 54.04K 366K 144K 1.78M 142K 139K 6.18M

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
Y.B URBAN RENEWAL - RESIDENTIAL DEVELOPMENT LTD	0.00%	0.00%	-19.77%	+61.15%	9.52M
NFINITI INC.	+27.66%	-99.80%	-99.25%	-	95.45B
SUN HUNG KAI PROPERTIES LIMITED	-1.87%	-2.11%	+30.77%	+23.48%	45.46B
MITSUBISHI ESTATE CO., LTD.	-1.72%	-5.34%	+40.54%	+132.72%	29.81B
CHINA RESOURCES LAND LIMITED	-3.88%	-5.60%	+10.41%	+1.81%	30.92B
EMAAR PROPERTIES	-0.36%	-4.15%	-26.62%	+66.37%	26.76B
MITSUI FUDOSAN CO., LTD.	0.00%	+0.06%	+15.89%	+64.86%	25.46B
SUMITOMO REALTY & DEVELOPMENT CO., LTD.	-0.41%	-3.79%	+35.84%	+101.81%	20.83B
CK ASSET HOLDINGS LIMITED	-0.87%	+1.18%	+29.63%	+9.49%	21.57B
ALPHA DHABI HOLDING	-0.68%	-2.93%	-39.57%	-63.90%	20.01B
Average	+1.79%	-1.31%	-2.21%	+44.20%	31.63B
Weighted average by Cap.	+7.38%	-1.08%	-19.79%	+43.26%